For those seeking more modest amounts of weight loss, any of the currently available medications are likely to work and the choice can be driven by a variety of factors: insurance coverage, availability, formulation (injection vs oral), and ease of access and use
At this point, there is no completed clinical evidence showing that ultra-low GLP-1 dosing prevents Alzheimers disease
The rates of obesity have steadily increased over the past few years with more individuals becoming candidates for this type of treatment, Dr
This class of drugs has also been found to lower the risk of cardiovascular disease and certain cancers
These agonists are developed to maximize metabolic benefits and reduce side effects (126)
Obesity and related diseases, including cardiovascular disease, hypertension, and type 2 diabetes, are leading causes of death in the U.S